ScienceMelanoma vaccine reportedly succeeds at preventing recurrence in a clinical trial
The Washington Post reports that experts call the result a breakthrough for mRNA-based treatments. Trials of mRNA vaccines for lung and pancreatic cancer are also underway, the newspaper says.
TLDR
A cancer vaccine succeeded in preventing melanoma from returning in a clinical trial, The Washington Post reports, with experts calling the result a breakthrough for mRNA-based treatments. The newspaper also reports that trials investigating mRNA vaccines for lung cancer, pancreatic cancer and other diseases are underway.
Melanoma vaccine reportedly succeeds at preventing recurrence in a clinical trial
The Washington Post reports that experts call the result a breakthrough for mRNA-based treatments. Trials of mRNA vaccines for lung and pancreatic cancer are also underway, the newspaper says.